Increasing evidence points to an important role for CCR9 in guiding mobilized, CCR9-expressing tumor cells to the gastrointestinal tract, notably the intestines, where its single ligand CCL25 is ubiquitously produced. This evidence concerns the gene CCR9 and neoplasm.